Elixa Mediscience Ltd
12312023
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/11/2025
micro entity
Next accounts due
31/08/2027
Confirmation statement
Last: 22/07/2026
Due 05/08/2027
Industry
Officers
director · Since 06/12/2022
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM
Also on 12 other boards
Persons with Significant Control
Prof Alan Michael Palmer
British · England
Notified 13/11/2019
Dr Michael John Hudson
British · United Kingdom
Notified 12/03/2024
Former PSCs
Dr Richard Simon Todd
Ceased 01/12/2021
Professor Patrick Angel Camilleri
Ceased 01/12/2021
CompanyRankvs 1857+ SIC 72110 peers46
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/11/2025
Net Worth
£111
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£27k
Working capital
Current Assets
£584
Current Liabilities
£28k
Fixed Assets
£28k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.02 | — |
| 2024 | 0.01 | +£7k |
| 2023 | 0.07 | — |
Derived from filed accounts. Not audited figures.